From Tracking Symptoms to Reading Biology: Femtech’s Next Phase Arrives in Canada as Ovulio Corp. names EndoDiagnosis, Inc. its Canadian distributor for Ovul, bringing the reusable saliva estrogen monitor to clinics and pharmacies.
endometriosis
First Canadian ENDOSURE baby after 7- years unexplained infertility
Ashleigh’s 7-year unexplained infertility story, 30-minute TIER-1 endometriosis diagnosis with ENDOSURE and Pregnancy 6 Weeks after Endometriosis Surgery in Vancouver. FIRST Canadian ENDOSURE Baby!
Understanding Endometriosis Diagnosis Methods
Gain insight into effective diagnosis techniques for endometriosis. Understanding these methods can lead to timely intervention and improved patient care.
Optimal Timing for Endometriosis Testing
Endometriosis is a common condition linked to pelvic pain, bloating, IBS and reduced fertility (amongst over 80+ symptoms). Determining when to test...
Edmonton Women’s Health Event Tackles Endometriosis Diagnosis
Edmonton, Alberta – Edmontonians are being invited to take part in the community led Women's Health Symposium taking place on April 25, 2026 at the...
Facing Unexplained Infertility? Know the Signs of Endometriosis & how to access rapid Endometriosis Diagnosis
A two-third majority of infertile women exhibit endometriosis. The prevalence of endometriosis in infertile women was higher than expected.
EndoDiagnosis, Inc Exhibits TIER-1 ENDOSURE Diagnostic Test for Endometriosis at AAGL 2025
EndoDiagnosis, Inc., is exhibiting at the American Association of Gynecologic Laparoscopists (AAGL) Global Congress taking place November 9-11,...
Recognizing Endometriosis Warning Signs
"I knew something wasn't right when my periods became increasingly painful, but my doctor kept dismissing it as normal cramping," shares Sarah, a...
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
A breakthrough in women’s health: The ENDOSURE test delivers 99.87% accurate, non-invasive results for endometriosis in under an hour, potentially transforming care and cutting years off diagnosis time. Despite its Health Canada approval, access remains limited. Clinicians and advocates urge wider adoption to reduce delays, improve outcomes, and support early intervention for the 1 in 10 women affected. EndoDiagnosis aims to bring access to testing to patients and clinics across Canada.